NPPA fixes retail price of 40 Formulation, Details
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 40 new drugs including those used to treat high blood pressure, type 2 diabetes, cholesterol, bacterial infections and those used to relieve gastric disease, muscle relaxant, pain and inflammation.
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1. | Telmisartan and Hydrochlorothi azide Tablets IP | Each Uncoated Bilayered Tablet Contains: Telmisartan IP 40mg Hydrochlorothiazide IP 12.5mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Sun Pharmaceuticals Industries Limited | 10.32 |
2. | Trastuzumab 375mg Injection | Lyophilized powder for intravenous infusion (to be supplied with bacteriostatic water for injection 20ml for reconstitution), Multi-use vial Each Lyophilized vial contains: Trastuzumab 375mg Excipients: L-Histidine Hydrochloride monohydrate EP 8.44mg L-Histidine USP 5.45mg α, α-Trehalose dihydrate NF 340.90mg Polysorbate 20NF 1.53mg pH 6.0 Diluent: Bacteriostatic water for injection 20ml for reconstitution | Per Vial | M/s Zydus Lifescience Ltd. | 12420.28 |
3. | Glimepiride, Voglibose& | Each uncoated bilayered tablet contains: | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. | 10.00 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Metformin (Extended- release) tablets | Glimepiride IP 1mg, Voglibose IP 0.2mg Metformin Hydrochloride IP 500mg (As Extended- release) | / M/s Apex Laboratories Pvt. Ltd. | |||
4. | Cholecalciferol (Vitamin D3) Oral Solution | Each 5ml contain: Cholecalciferol IP 60000 IU (In nano Droplet form) | 1 ML | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd. | 12.03 |
5. | Ibuprofen and Paracetamol Tablets IP | Each uncoated tablet contains: Ibuprofen IP 400mg Paracetamol IP 325mg | 1 Tablet | M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd. / M/s Mankind Prime Labs Ltd. | 1.45 |
6. | Myo-Inositol, Melatonin & Folic Acid Tablets | Each film coated tablet contains: Myo-Inositol USP 1gm Melatonin BP 1.5mg Folic Acid IP 1000mcg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 20.93 |
7. | Ibuprofen & Paracetamol Tablets | Each uncoated tablet contains: Ibuprofen IP 400mg Paracetamol IP 325mg | 1 Tablet | M/s Innova Captab Limited / M/s Abbott India Limited | 1.45 |
8. | Olmesartan Medoxomil& Amlodipine Tablets | Each Film Coated Tablet contains: Olmesartan Medoxomil IP 20mg Amlodipine Besilate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Hetero Labs Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 11.41 |
9. | Ibuprofen and Paracetamol Suspension | Each 5ml contains: Ibuprofen IP 100mg Paracetamol IP 162.5mg | 1 ml | M/s Innova Captab Limited / M/s Abbott India Limited | 0.41 |
10. | Olmesartan Medoxomil, Amlodipine & Hydrochlorothi azide Tablets | Each Film Coated Tablet contains: Olmesartan Medoxomil IP 20mg Amlodipine Besilate IP eq. to Amlodipine 5mg Hydrochlorothiazide IP 12.50mg | 1 Tablet | M/s Pharma Force Lab. / M/s Mankind Prime Labs Pvt. Ltd. | 13.24 |
11. | Olmesartan Medoxomil& Amlodipine Tablets | Each Film Coated Tablet contains: Olmesartan Medoxomil IP 40mg Amlodipine Besilate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Hetero Labs Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 18.77 |
12. | Paracetamol & Mefenamic Acid Suspension | Each 5ml contains: Paracetamol IP 250mg Mefenamic Acid 100mg | 1 ml | M/s Pharma Force Lab. / M/s Mankind Prime Labs Pvt. Ltd. | 0.75 |
13. | Telmisartan, | Each film coated | 1 Tablet | M/s Ravenbhel | 9.51 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Metformin (Extended- release) tablets | Glimepiride IP 1mg, Voglibose IP 0.2mg Metformin Hydrochloride IP 500mg (As Extended- release) | / M/s Apex Laboratories Pvt. Ltd. | |||
4. | Cholecalciferol (Vitamin D3) Oral Solution | Each 5ml contain: Cholecalciferol IP 60000 IU (In nano Droplet form) | 1 ML | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd. | 12.03 |
5. | Ibuprofen and Paracetamol Tablets IP | Each uncoated tablet contains: Ibuprofen IP 400mg Paracetamol IP 325mg | 1 Tablet | M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd. / M/s Mankind Prime Labs Ltd. | 1.45 |
6. | Myo-Inositol, Melatonin & Folic Acid Tablets | Each film coated tablet contains: Myo-Inositol USP 1gm Melatonin BP 1.5mg Folic Acid IP 1000mcg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 20.93 |
7. | Ibuprofen & Paracetamol Tablets | Each uncoated tablet contains: Ibuprofen IP 400mg Paracetamol IP 325mg | 1 Tablet | M/s Innova Captab Limited / M/s Abbott India Limited | 1.45 |
8. | Olmesartan Medoxomil& Amlodipine Tablets | Each Film Coated Tablet contains: Olmesartan Medoxomil IP 20mg Amlodipine Besilate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Hetero Labs Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 11.41 |
9. | Ibuprofen and Paracetamol Suspension | Each 5ml contains: Ibuprofen IP 100mg Paracetamol IP 162.5mg | 1 ml | M/s Innova Captab Limited / M/s Abbott India Limited | 0.41 |
10. | Olmesartan Medoxomil, Amlodipine & Hydrochlorothi azide Tablets | Each Film Coated Tablet contains: Olmesartan Medoxomil IP 20mg Amlodipine Besilate IP eq. to Amlodipine 5mg Hydrochlorothiazide IP 12.50mg | 1 Tablet | M/s Pharma Force Lab. / M/s Mankind Prime Labs Pvt. Ltd. | 13.24 |
11. | Olmesartan Medoxomil& Amlodipine Tablets | Each Film Coated Tablet contains: Olmesartan Medoxomil IP 40mg Amlodipine Besilate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Hetero Labs Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 18.77 |
12. | Paracetamol & Mefenamic Acid Suspension | Each 5ml contains: Paracetamol IP 250mg Mefenamic Acid 100mg | 1 ml | M/s Pharma Force Lab. / M/s Mankind Prime Labs Pvt. Ltd. | 0.75 |
13. | Telmisartan, | Each film coated | 1 Tablet | M/s Ravenbhel | 9.51 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Chlorthalidone & Metoprolol ER Tablets | bilayered tablet contains: Telmisartan IP 40mg Chlorthalidone IP 6.25mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as Extended release) 25mg | Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | |||
14. | Telmisartan, Chlorthalidone & Metoprolol ER Tablets | Each film coated bilayered tablet contains: Telmisartan IP 40mg Chlorthalidone IP 6.25mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as Extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 10.88 |
15. | Paracetamol Bilayered Sustained Release Tablets | Each uncoated bilayered sustained release tablet contains: Paracetamol IP (as Immediate release) 300mg Paracetamol IP (as Sustained release) 700mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zydus Healthcare Limited | 4.15 |
16. | Glimepiride and Metformin Hydrochloride (ER) Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 4mg Metformin Hydrochloride IP 1000mg (In extended- release form) | 1 Tablet | M/s Innova Captab Ltd. / M/s Cipla Ltd. | 10.87 |
17. | Glimepiride and Metformin Hydrochloride (ER) Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 3mg Metformin Hydrochloride IP 1000mg (In extended- release form) | 1 Tablet | M/s Innova Captab Ltd. / M/s Cipla Ltd. | 10.18 |
18. | Glimepiride and Metformin Hydrochloride (ER) Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 3mg Metformin Hydrochloride IP 500mg (In extended- release form) | 1 Tablet | M/s Innova Captab Ltd. / M/s Cipla Ltd. | 9.66 |
19. | Glimepiride and Metformin Hydrochloride (ER) Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 4mg Metformin Hydrochloride IP 500mg (In extended- release form) | 1 Tablet | M/s Innova Captab Ltd. / M/s Cipla Ltd. | 10.36 |
20. | Amoxycillin and Potassium Clavulanate Oral Suspension IP | Each Combipack contains: (A) Amoxycillin and Potaassium Clavulanate Oral Suspension IP | Each Combi Pack | M/s Malik Life Sciences Pvt. Ltd. / M/s Cipla Limited | 168.43 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Composition: Each 5ml of reconstituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 600mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 42.9mg (B) 2 Ampoules of 25ml each of sterile water for reconstitution of Dry syrup | |||||
21. | Olmesartan Medoxomil, Amlodipine &Hydrochlorot hiazideTablet | Each film coated tablet contains: Olmesartan Medoxomil IP 40mg Amlodipine Besilate IP eq. to Amlodipine 5mg Hydrochlorothiazide IP 12.5mg | 1 Tablet | M/s Pharma Force Lab. / M/s Mankind Prime Labs Pvt. Ltd. | 17.59 |
22. | Diclofenac Diethylamine, Methyl Salicylate & Menthol Topical Spray | Composition: Diclofenac Diethylamine IP 2.32% w/w (eq. to Diclofenac Sodium 2% w/w) Methyl Salicylate IP 10% w/w Menthol IP 5% w/w | 1 Gram | M/s Pontika Aerotech Limited / M/s Zydus Healthcare Limited | 3.14 |
23. | Glycopyrrolate + Neostigmine Methylsulphate Injection | Each 5ml contains: Glycopyrrolate IP 0.5mg Neostigmine MethylsulphateIP 2.5mg Water for Injection IP q.s. | 5 ml Ampoule | M/s Samarth Life Sciences Pvt. Ltd. | 51.19 |
24. | Pantoprazole Dual Release Gastro Resistant Tablets | Each Dual Release Gastro Resistant Tablet Contains: Pantoprazole Sodium Eq. to Pantoprazole 80mg | 1 Tablet | M/s Pure and Care Healthcare Pvt. Ltd. / M/s Cipla Limited | 15.58 |
25. | Olmesartan Medoxomil and Amlodipine Besylate Tablet | Each film coated tablet contains: Olmesartan Medoxomil BP 20mg Amlodipine Besylate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Cadila Pharmaceuticals Limited | 11.61 |
26. | Pantoprazole Dual-Release Gastro- Resistant Tablets | Each Dual-release Gastro-resistant tablet contains: Pantoprazole Sodium IP eq. to Pantoprazole 80mg | 1 Tablet | M/s Zydus Healthcare Limited | 15.58 |
27. | Pantoprazole powder for Oral | Each sachet contains: Pantoprazole Sodium IP eq. to Pantoprazole 40mg | 1 Sachet of 5gm | M/s Alkem Laboratories Ltd. | 9.05 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Suspension (Sodium Bicarbonate as buffer) | (Sodium Bicarbonate as buffer) | ||||
28. | Atorvastatin &Bempedoic Acid Tablet | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 80mg Bempedoic Acid 180mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited | 50.71 |
29. | Atorvastatin &Bempedoic Acid Tablet | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 80mg Bempedoic Acid 180mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Sun Pharma Laboratories Limited | 50.71 |
30. | Telmisartan and Bisoprolol Tablets | Each film coated tablet contains: Telmisartan IP 40mg Bisoprolol Fumarate IP 5mg | 1 Tablet | M/s Micro labs Ltd. | 11.81 |
31. | Sitagliptin and Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100mg Metformin Hydrochloride IP 1000mg (as Extended Release) | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Lupin Limited | 21.56 |
32. | Sitagliptin and Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg (as Extended Release) | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Unison Pharmaceuticals Pvt. Ltd. | 18.67 |
33. | Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Mediforce Healthcare Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 18.34 |
34. | Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Mediforce Healthcare Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 20.02 |
35. | Sitagliptin and Metformin | Each film coated bilayered tablet contains: | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / | 20.06 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Hydrochloride (ER)Tablets | Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg (as Extended Release) | M/s Unison Pharmaceuticals Pvt. Ltd. | |||
36. | Sitagliptin and Metformin Hydrochloride (ER)Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100mg Metformin Hydrochloride IP 500mg (as Extended Release) | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Unison Pharmaceuticals Pvt. Ltd. | 20.17 |
37. | Sitagliptin and Metformin Hydrochloride (ER)Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100mg Metformin Hydrochloride IP 1000mg (as Extended Release) | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Unison Pharmaceuticals Pvt. Ltd. | 21.56 |
38. | Dapagliflozin, Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets | Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100mg Metformin Hydrochloride IP 1000mg (as Extended Release) | 1 Tablet | M/s Sun Pharma Laboratories Limited | 22.32 |
39. | Dapagliflozin, Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets | Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100mg Metformin Hydrochloride IP 500mg (as Extended Release) | 1 Tablet | M/s Alkem Laboratories Limited | 29.31 |
40. | Dapagliflozin, Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets | Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Sitagliptin Phosphate Monohydrate eq. to | 1 Tablet | M/s Alkem Laboratories Limited | 30.70 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Sitagliptin 100mg Metformin Hydrochloride IP 1000mg (as Extended Release) |
The notification further added,
(a) The manufacturer of above-mentioned formulations i.e., "new drug" under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd